Company Overview

ABCELLERA BIOLOGICS INC.

ABCL
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
75M
2025 FY
Net Income
-146M
2025 FY
Shares Outstanding
299M
2025 FY
EPS
-0.49USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1703057
Exchange
Nasdaq
Location
CA